Holm J P, Amar A O S, Hyldstrup L, Jensen J E B
Department of Endocrinology, Copenhagen University Hospital Hvidovre, Kettegaards Allé 30, DK-2650, Hvidovre, Denmark.
Osteoporos Int. 2016 Mar;27(3):989-1001. doi: 10.1007/s00198-015-3370-0. Epub 2015 Oct 23.
SUMMARY: Hyponatremia has been linked to an increased risk of osteoporosis and fractures. We found an increased hazard ratio of major osteoporotic fractures adjusted for potential confounders, including osteoporosis and medication. A reduced BMD was not sufficiently explaining the association. Our data indicate that hyponatremia should be considered a risk factor for osteoporosis and fractures. INTRODUCTION: Hyponatremia is the most common electrolyte disorder in clinical practice and could be a risk factor for both osteoporosis and fractures. Mild hyponatremia has traditionally been regarded as a benign and asymptomatic condition; however, data from large population and animal studies have led to a reappraisal of this view. The purpose of this study was to evaluate the association of hyponatremia with osteoporosis and major osteoporotic fractures (MOF) in women. METHODS: This is a historical cohort study with fracture follow-up. The study consisted of 5610 patients with available serum sodium and a bone density measurement. Information on potential risk factor was obtained through a questionnaire. Additional information on medication, comorbidities, and fractures was obtained through national registries. RESULTS: Hyponatremia was associated with significant lower T-scores at total hip and a borderline significant lower T-score at femoral neck in the multivariate analysis. No association was found between hyponatremia and the lumbar spine T-score. Hyponatremia was associated with an increased hazard ratio of sustaining a MOF in the period from 6 months prior to 12 months after serum sodium measurement. Finally, data showed a relationship with increasing serum sodium and an increasing T-score estimate and a decreasing hazard ratio of MOF. CONCLUSIONS: Our data suggest that hyponatremia in women increases the risk of osteoporosis and MOF. The increased risk of MOF was independent of osteoporosis.
摘要:低钠血症与骨质疏松症及骨折风险增加有关。我们发现,在对包括骨质疏松症和药物治疗等潜在混杂因素进行校正后,严重骨质疏松性骨折的风险比有所增加。骨密度降低并不能充分解释这种关联。我们的数据表明,低钠血症应被视为骨质疏松症和骨折的一个风险因素。 引言:低钠血症是临床实践中最常见的电解质紊乱,可能是骨质疏松症和骨折的一个风险因素。传统上,轻度低钠血症被视为一种良性且无症状的病症;然而,来自大型人群和动物研究的数据促使人们对这一观点进行重新评估。本研究的目的是评估低钠血症与女性骨质疏松症及严重骨质疏松性骨折(MOF)之间的关联。 方法:这是一项有骨折随访的历史性队列研究。该研究包括5610名有可用血清钠和骨密度测量值的患者。通过问卷调查获取潜在风险因素的信息。通过国家登记处获取有关药物治疗、合并症和骨折的其他信息。 结果:在多变量分析中,低钠血症与全髋部T值显著降低以及股骨颈T值临界显著降低相关。未发现低钠血症与腰椎T值之间存在关联。低钠血症与血清钠测量前6个月至测量后12个月期间发生MOF的风险比增加有关。最后,数据显示血清钠升高与T值估计增加以及MOF风险比降低之间存在关联。 结论:我们的数据表明,女性低钠血症会增加骨质疏松症和MOF的风险。MOF风险增加独立于骨质疏松症。
Osteoporos Int. 2016-3
Osteoporos Int. 2015-3
Osteoporos Int. 2016-1
Medicine (Baltimore). 2024-12-13
J Clin Endocrinol Metab. 2025-2-18
BMC Musculoskelet Disord. 2024-1-15
Ther Adv Endocrinol Metab. 2023-9-18
Arthroplast Today. 2023-1-16
J Clin Endocrinol Metab. 2015-8
Med Clin North Am. 2015-5
Osteoporos Int. 2015-9
Osteoporos Int. 2015-3